Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data von van der Velden, V H J, Cazzaniga, G, Schrauder, A, Hancock, J, Bader, P, Panzer-Grumayer, E R, Flohr, T, Sutton, R, Cave, H, Madsen, H O, Cayuela, J M, Trka, J, Eckert, C, Foroni, L, zur Stadt, U, Beldjord, K, Raff, T, van der Schoot, C E, van Dongen, J J M

Volltext

Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review von Kamphuis, MM, Paridaans, N, Porcelijn, L, De Haas, M, van der Schoot, CE, Brand, A, Bonsel, GJ, Oepkes, D

Volltext

Improved flow cytometric detection of minimal residual disease in childhood acute lymphoblastic leukemia von Denys, B, van der Sluijs-Gelling, A J, Homburg, C, van der Schoot, C E, de Haas, V, Philippé, J, Pieters, R, van Dongen, J J M, van der Velden, V H J

Volltext

Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia von Waanders, E, van der Velden, V H J, van der Schoot, C E, van Leeuwen, F N, van Reijmersdal, S V, de Haas, V, Veerman, A J, van Kessel, A Geurts, Hoogerbrugge, P M, Kuiper, R P, van Dongen, J J M

Volltext

Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7‐year clinical experience von Scheffer, PG, van der Schoot, CE, Page‐Christiaens, GCML, de Haas, M

Volltext

Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitat... von VAN DER VELDEN, V. H. J, WILLEMSE, M. J, VAN DER SCHOOT, C. E, HÄHLEN, K, VAN WERING, E. R, VAN DONGEN, J. J. M

Volltext

Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia von VERHAGEN, O. J. H. M, WILLEMSE, M. J, BREUNIS, W. B, WIJKHUIJS, A. J. M, JACOBS, D. C. H, JOOSTEN, S. A, VAN WERING, E. R, VAN DONGEN, J. J. M, VAN DER SCHOOT, C. E

Volltext

Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands von Koelewijn, J.M., Vrijkotte, T.G.M., Van Der Schoot, C.E., Bonsel, G.J., De Haas, M.

Volltext

Migratory behavior of leukemic cells from acute myeloid leukemia patients von VOERMANS, C, VAN HEESE, W. P. M, DE JONG, I, GERRITSEN, W. R, VAN DER SCHOOT, C. E

Volltext

Predicting anti-RhD titers in donors: Boostering response and decline rates are personal von de Vos, Anneke S, van der Schoot, Ellen C E, Rizopoulos, Dimitris, Janssen, Mart P

Volltext

The prognostic value of fast molecular response of marrow disease in patients aged over 1 year with stage 4 neuroblastoma von Stutterheim, J, Zappeij-Kannegieter, L, Versteeg, R, Caron, H.N, van der Schoot, C.E, Tytgat, G.A.M

Volltext

Noninvasive fetal genotyping of human platelet antigen‐1a von Scheffer, PG, Ait Soussan, A, Verhagen, OJHM, Page‐Christiaens, GCML, Oepkes, D, de Haas, M, van der Schoot, CE

Volltext

Detection of fetal RHD-specific sequences in maternal plasma von Faas, BHW, Beuling, EA, Christiaens, GC ML, von dem Borne, AEG Kr, van der School, CE

Volltext

Germline activating TYK2 mutations in pediatric patients with two primary acute lymphoblastic leukemia occurrences von Waanders, E, Scheijen, B, Jongmans, M C J, Venselaar, H, van Reijmersdal, S V, van Dijk, A H A, Pastorczak, A, Weren, R D A, van der Schoot, C E, van de Vorst, M, Sonneveld, E, Hoogerbrugge, N, van der Velden, V H J, Gruhn, B, Hoogerbrugge, P M, van Dongen, J J M, Geurts van Kessel, A, van Leeuwen, F N, Kuiper, R P

Volltext

Risk factors for RhD immunisation despite antenatal and postnatal anti‐D prophylaxis von Koelewijn, JM, de Haas, M, Vrijkotte, TGM, van der Schoot, CE, Bonsel, GJ

Volltext

Haemolytic disease of the fetus and newborn von de Haas, M., Thurik, F. F., Koelewijn, J.M., van der Schoot, C.E.

Volltext

Blood group genotyping: from patient to high-throughput donor screening von Veldhuisen, B., Van Der Schoot, C. E., De Haas, M.

Volltext

Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes von PONGERS-WILLEMSE, M. J, VERHAGEN, O. J. H. M, TIBBE, G. J. M, WIJKHUIJS, A. J. M, DE HAAS, V, ROOVERS, E, VAN DER SCHOOT, C. E, VAN DONGEN, J. J. M

Volltext

Quantification of minimal residual disease in children with oligoclonal B-precursor acute lymphoblastic leukemia indicates that the clones that grow out during relapse already have... von DE HAAS, V, VERHAGEN, O. J. H. M, VON DEM BORNE, A. E. G. Kr, KROES, W, VAN DEN BERG, H, VAN DER SCHOOT, C. E

Volltext

Immortalisation of human bone marrow endothelial cells: characterisation of new cell lines von ROOD, P. M. L, CALAFAT, J, VON DEM BORNE, A. E. G. K, GERRITSEN, W. R, VAN DER SCHOOT, C. E

Volltext